Can tuberculosis be controlled?

International Journal of Epidemiology

Volumn 31, Issue 5, 2002, Pages 894-899

  Frieden, Thomas R ^a  

^a Department of Health ^*  (United States)

Author keywords

Burden of disease; Disease control; Short course chemotherapy; Tuberculosis

Indexed keywords

DISEASE CONTROL; DISEASE INCIDENCE; HUMAN IMMUNODEFICIENCY VIRUS; PUBLIC HEALTH; TUBERCULOSIS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; HEALTH CARE POLICY; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; INFECTION RATE; MEDICAL TECHNOLOGY; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SPUTUM SMEAR; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 0036816899     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/31.5.894     Document Type: Review

References (41)

1. McKeown T. The Role of Medicine. Princeton: Princeton University Press, 1979.
2. Frieden TR. Tuberculosis control and social change. Am J Public Health 1994;84:1721-23.
3. Styblo K, Bumgarner JR. Tuberculosis can be controlled with existing technologies: evidence. Tuberculosis Surveillance Research Unit, Progress Report, 1991, pp. 60-72.
4. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City-turning the tide. New Engl J Med 1995;333:229-33.
5. Suarez PG, Watt CJ, Alarcon E et al. The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. J Infect Dis 2001;184:473-78.
6. Marrero A, Caminero JA, Rodriguez R, Billo NE. Towards elimination of tuberculosis in a low-income country: the experience of Cuba, 1962-97. Thorax 2000;55:39-45.
7. World Health Organization. Treatment of Tuberculosis, Guidelines for National Programmes. Geneva: World Health Organization, 1997.
8. Hinshaw HC, Feldman WH. Streptomycin in the treatment of clinical tuberculosis: a preliminary report. Proc Staff Meet Mayo Clinic 1945; 20:313-18.
9. Crofton J. The contribution of treatment to the prevention of tuberculosis. Bull Int Union Tuberc 1962;32:643-53.
10. Styblo K. Epidemiology of Tuberculosis. Vol. 24. The Hague, Royal Netherlands Tuberculosis Association, 1984.
11. Datta M, Radhamani MP, Selvaraj R et al. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme. Tuberc Lung Dis 1993;74:180-86.
12. Global Tuberculosis Control: WHO Report 2001. Geneva: World Health Organization, 2001 (WHO/CDS/TB/2001.287).
13. www.tbcindia.org/method.asp
14. Dye C, Fengzeng Z, Scheele S, Williams BG. Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China. Int J Epidemiol 2000;29:558-64.
15. Tuberculosis Research Centre, Chennai. Trends in the prevalence and incidence of tuberculosis in South India. Int J Tuberc Lung Dis 2001; 5:142-57.
16. Khatri GR, Frieden TR. The status and prospects of tuberculosis control in India. Int J Tuberc Lung Dis 2000;4:193-200.
17. Styblo K, Dankova D, Drapela J et al. Epidemiological and clinical study of tuberculosis in the district of Kolín, Czechoslovakia. Bull World Health Org 1967;37:819-74.
18. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cairthen GM, Dooley SW. The emergence of drug resistant tuberculosis in New York City. N Engl J Med 1993;328:521-26.
19. Fujiwara PI, Cook SV, Rutherford CM et al. A continuing survey of drug-resistant tuberculosis, New York City, April 1994. Arch Int Med 1997;157:531-36.
20. Zhang LX, Tu DH, Enarson DA. The impact of directly-observed treatment on the epidemiology of tuberculosis in Beijing. Int J Tuberc Lung Dis 2000;4:904-10.
21. Frimodt-Moller J. A community wide tuberculosis study in a south Indian rural population, 1950-55, Bull World Health Organ 1960;22: 61-170.
22. Frost WH. How much control of tuberculosis? Am J Public Health 1937;27:759-66.
23. Styblo K. Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries. Rev Infect Dis 1989;11:S339-46.
24. Styblo K. Epidemiology of Tuberculosis. Vol. 24. The Hague, Royal Netherlands Tuberculosis Association, 1984, p. 97.
25. Kaplan GJ, Fraser RI, Comstock GW. Tuberculosis in Alaska, 1970. The continued decline of the tuberculosis epidemic. Am Rev Respir Dis 1972;105:920-26.
26. World Health Organization, International Union Against Tuberculosis and Lung Disease, Royal Netherlands Tuberculosis Association. Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis 2001;5:213-15.
27. Neuenschwander BE, Zwahlen M, Kim SJ, Engel RR, Rieder HL. Trends in the prevalence of infection with Mycobacterium tuberculosis in Korea from 1965 to 1995: an analysis of seven surveys by mixture models. Int J Tuberc Lung Dis 2000;4:719-29.
28. Heldal E, Docker H, Caugant DA et al. Pulmonary tuberculosis in Norwegian patients. The role of reactivation, re-infection and primary infection assessed by previous mass screening data and restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis 2000;4: 300-07.
29. Tuberculosis Information Summary-1999. New York, New York City Department of Health, 2000.
30. Jasmer RM, Hahn JA, Small PM et al. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med 1999;130:971-78.
31. Frieden TR, Woodley CL, Crawford JT, Lew D, Dooley S. The molecular epidemiology of tuberculosis in New York City: the importance of nosocomial transmission and laboratory error. Tuber Lung Dis 1996; 77:407-13.
32. Diaz R, Kremer K, de Haas PE et al. Molecular epidemiology of tuberculosis in Cuba outside of Havana, July 1994-June 1995: utility of spoligotyping versus IS6110 restriction fragment length polymorphism. Int J Tuberc Lung Dis 1998;2:743-50.
33. Yang ZH, Mtoni I, Chonde M et al. DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania. J Clin Microbiol 1995;33:1064-69.
34. Garcia-Garcia M, Palacios-Martinez M, Ponce-de-Leon A et al. The role of core groups in transmitting Mycobacterium tuberculosis in a high prevalence community in Southern Mexico. Int J Tuberc Lung Dis 2000;4:12-17.
35. Wilkinson D, Pillay M, Crump J, Lombard C, Davies GR, Sturm AW. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in rural Africa. Trop Med Int Health 1997;2:747-53.
36. Kenyon TA, Mwasekaga MJ, Huebner R, Rumisha D, Binkin N, Maganu E. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. Int J Tuberc Lung Dis 1999;3:4-11.
37. Cantwell MF, Binkin NJ. Tuberculosis in sub-Saharan Africa: a regional assessment of the impact of the human immunodeficiency virus and national tuberculosis control program quality. Tuber Lung Dis 1996;77:220-26.
38. Royal Netherlands Tuberculosis Association and International Tuberculosis Surveillance, The Hague. Tuberculosis control in the era of the HIV epidemic: risk of tuberculosis infection in Tanzania, 1983-1998. Int J Tuberc Lung Dis 2001;5:103-12.
39. Styblo K. Eradication of tuberculosis in developed countries in the HIV era. Bull Int Union Tuber Lung Dis 1989;64:58-64.
40. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991;144:745-49.
41. Dye C. Tuberculosis 2000-2010: control, but not elimination. Int J Tuberc Lung Dis 2000;4(Suppl.):S146-52.